Latest News
vivoVerse moves into new HQ
vivoVerse has expanded its base of operations into a customized, newly refurbished space in Austin, Texas. . Here, we lead you on a quick tour of the company’s new home..
vivoVerse awarded SBIR Phase II grant from NIMH
vivoVerse (formerly operating as Newormics) is excited to announce it has been awarded a $2.25M Phase II SBIR grant from the National Institutes of Health/National Institute of Mental Health (NIMH) for the continued development of the company’s in vivo imaging and screening technologies.
vivoVerse Announces Intent to Grant Utility Patent on the vivoChip by the European Patent Office
vivoVerse (formerly operating as Newormics), a developer of the first high-throughput, high-content screening platforms for use with in vivo small animal models, announced that the European Patent Office (EPO) intends to grant a patent covering the vivoChip® technology, the device design and use for C. elegans studies.
More news...
